Pathological complete response to preoperative avelumab treatment in a patient with advanced Merkel cell carcinoma

Dermatol Online J. 2022 Oct 15;28(5). doi: 10.5070/D328559252.

Authors

Haruki Mizuta, Dai Ogata¹, Shunichi Jinnai, Kenjiro Namikawa, Akira Takahashi, Naoya Yamazaki

Affiliation

¹ Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. dogata@ncc.go.jp.

PMID: 36809143
DOI: 10.5070/D328559252

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized
Carcinoma, Merkel Cell* / pathology
Humans
Skin Neoplasms* / pathology

Substances

avelumab
Antibodies, Monoclonal, Humanized